2025 Congress Edition

Congress Editions – 2025 Highlights

3rd Edition of the Region’s Most Impactful Stem Cell Gathering

Dubai Stem Cell Congress 2025 continues its journey as the region’s most prominent platform for regenerative medicine. This year features expanded sessions, live success stories, patient-centered empowerment, academic showcases, and immersive workshops to elevate knowledge-sharing and clinical excellence.

Countries
0
Attendees
0 +
Speakers/Patients
0 +
Exhibitors
0 +

Speakers

Dr. Fatma Alhashimi

CEO and Chairperson of Dubai Stem Cell Congress

Dr. Edward Guindi

Gynaecologist & Former CEO Cord: USE USA

Khadija Alsulaimi

Chairperson, ENA Midwifery Society Director, Nursing Department Latifa Women & Children Hospital, UAE

Dr. Essam Abdelalim

Principle Investigator Head, Laboratory of Pluripotent Stem Cell Disease Modeling Sidra Medicine, Qatar

Dr. Sarkawt Hamad

Regenerative Medicine Scientist Marga-and-Walter-Boll Laboratory for Cardiac Tissue Engineering, Germany

Mrs. Kim Petrella

Nurse Coordinator, Delaware Perinatal Quality Collaborative USA

Prof. John Wagner, MD

Director of the Institute for Cell Gene and Immunotherapies University of Minnesota, USA

Prof. Kurt Pfannkuche

Medical Faculty University of Cologne Marga-and Walter Bolls Laboratory for Cardiac Tissue Engineering, Germany

Prof. Dimitrios Mougiakakos

Director of Department of Hematology, Oncology, and Cell Therapy Otto-von-Guericke University Magdeburg, Germany

Dr. Peter Dröge

Associate Professor (Emeritus) School of Biological Sciences, Nanyang Technological University (NTU), Singapore

Prof. Jennifer Zhang

Professor, Department of Dermatology and Pathology Duke University, School of Medicine, North Carolina, USA

Dr. Ulf Grawunder

Co-founder & CEO T-CURX GmbH Würzburg, Germany

Prof. Yi Zhang, China

Executive Director Zhongyuan Cellular and Immunotherapy Laboratory Henan, China

Prof. Jeffrey Miller

Professor of Medicine Section Head, BMT and Cell Therapy Division of Hematology, Oncology and Transplantation Deputy Director, Masonic Cancer Center University of Minnesota, Cancer Center Minneapolis, MN, USA

Dr. Shinsuke Yoshida

Senior Manager Research and Development Center CiRA Foundation, Kyoto University, Japan

Prof. Jun Wu, MD, PhD

Associate Professor Department of Molecular Biology UT Southwestern Medical Center Dallas, TX, USA

Prof. Koichi Nakayama, MD, PhD

Professor and Chairman, Department of Regenerative Medicine and Biomedical Engineering,Faculty of Medicine, Saga University

Prof. Peterson Quinn

Senior Associate Consultant Assistant Professor of Physiology and Biomedical Engineering Mayo Clinic, Rocheste, MN, USA

Dr. Sai Kiang Lim

Research Director Paracrine Therapeutics Singapore

Prof. Dr. rer. nat. Bernd Giebel

Professor, University Hospital Essen Founder and Chief Scientific Officer Exosla Therapeutics, Germany

Prof Ke Cheng

Professor of Biomedical Engineering Columbia University New York

Prof. Halvard Bönig

Professor of Transfusion Medicine, Translational Development of Cellular Therapies Institute for Transfusion Medicine and Immunohematology Goethe University Frankfurt, Germany

Prof. John Rasko

Faculty of Medicine & Health, The University of Sydney Head of Department, Cell & Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District Deputy Director & Head, Gene and Stem Cell Therapy Program, Centenary Institute

Prof. Klaus Cichutek

Former President, Paul- Ehrlich-Institut (PEI) Associate Professor of Biochemistry Goethe University Frankfurt, Germany

Dr. Laura Barrachin Porcar

Senior Scientist “Manuel López” fellow School of Veterinary Animal Anatomy, Embryology and Genetics, Spain

Dr. Felician Stancioiu

Medical Director Bio-Forum Foundation Bucharest, Romania

Didier Nouzies

Chairman and CEO CORDSAVINGS SA Stem Cells Biobank Monthey, Switzerland

Dr. Khulood Mohamed Alsayegh

Head of Clinical Standards and Guidelines Section, Health Policies and Standard Department Dubai Health Authority, UAE

Welcome from the Chairperson

“It gives us great pleasure to welcome you to the Dubai Stem Cell Congress 2025 – 3rd Edition, held at the prestigious Ritz-Carlton DIFC, Dubai.”

As we gather on the 25th and 26th of February, we invite you to join us in a dynamic exchange of thought leadership and clinical insight across the fields of stem cell research and regenerative medicine.

With “Connecting Hope” as our foundational platform and our new theme “Bridging the Future”, we aim to unite top global minds, explore revolutionary technologies, and build transformative pathways toward a healthier tomorrow. Our congress is more than a gathering – it’s a call to action to redefine healthcare through collaboration, patient success, and relentless innovation.

Congress 2025 Objectives

The Dubai Stem Cell Congress 2025 was initiated and powered by First Stem Cell and Genomics Laboratory, with the mission to:

Facilitate Knowledge Exchange:
Bring together global leaders to share cutting-edge research and therapies.

Patient Empowerment: Share real-life stories to showcase tangible transformation through therapy.

Raise Awareness: Highlight innovations in stem cell treatments and their impact on patient outcomes.

Address Challenges: Tackle practical barriers and promote scalable medical applications.

Scientific Program & Highlights

01

Immune Effector Cell Therapy : Breakthroughs in CAR-T, NK cells, and other immune-based treatments

02

Induced Pluripotent Stem Cells (iPSCs)  Applications in regenerative medicine and disease modeling

03

Exosomes & EVs:
Joint session with ISCT exploring extracellular vesicle therapies

04

Clinical Trial Design & Stem Cell Regulation: Navigating approvals, ethics, and study frameworks

05

Cord Blood and Tissue Therapies: Advances in clinical applications and biobanking

06

Awarding Ceremony:
Honoring innovations, researchers, and patient contributions

About Connecting Hope

“Connecting Hope” is the foundational initiative behind DSCC, symbolized by a tree that represents the ever-growing knowledge of regenerative science. It is more than a motto – it is a movement toward inclusive healthcare innovation.

Theme 2025: Bridging the Future

In 2025, the Dubai Stem Cell Congress holds special significance as we proudly present the theme, “Bridging the Future”.

This new theme aims to showcase how we can create bridges to the latest technologies and innovations by connecting and inviting top scientists and researchers to Dubai-UAE.

Testimonials & Patient Stories

Hear from individuals whose lives have been transformed by stem cell therapy. These stories celebrate resilience, science, and the power of hope.

The PREMIER Stem Cell
Congress of 2025
in March 2025 – Dubai

Join us at the forefront of regenerative medicine, where global experts, clinicians, researchers, and innovators converge.

Why 2026 is a Turning Point

Fill the form

Register Your Interest

Registration will open soon...